当前位置:首页 - 行情中心 - 药康生物(688046) - 财务分析 - 资产负债表

药康生物

(688046)

  

流通市值:70.44亿  总市值:70.44亿
流通股本:4.10亿   总股本:4.10亿

资产负债表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
流动资产:
  货币资金304,333,782.27522,037,439.43344,988,138.76701,371,554.95
  交易性金融资产894,153,632.16670,253,369.98767,697,876.81467,337,452.06
  应收票据及应收账款426,696,176.99415,219,261.85392,912,399.63350,806,495.58
  其中:应收票据--299,999.6-
        应收账款426,696,176.99415,219,261.85392,612,400.03350,806,495.58
  预付款项9,239,887.915,396,397.687,674,740.184,562,582.1
  其他应收款合计4,855,992.235,393,009.066,591,049.016,279,399.27
  存货69,474,356.5662,563,165.2458,534,609.7754,196,734.18
  一年内到期的非流动资产-22,098,876.5276,742,040.73109,330,342.1
  其他流动资产82,564,918.9178,799,195.8764,280,571.2715,889,284.1
  流动资产合计1,791,318,747.031,781,760,715.631,719,421,426.161,709,773,844.34
非流动资产:
  长期股权投资90,657,541.3391,625,786.2778,901,011.9280,042,730.26
  其他权益工具投资10,499,9528,999,9528,999,9528,999,952
  其他非流动金融资产10,191,095.9210,128,082.2110,065,753.4310,004,109.59
  固定资产470,113,636.49477,741,529.49486,063,001.01493,221,530.68
  在建工程118,655,229.71112,267,165.5599,029,856.3690,852,441.13
  生产性生物资产7,270,802.777,113,947.756,835,317.595,730,187.72
  使用权资产58,045,140.6758,910,426.2365,929,050.3736,471,839.78
  无形资产49,045,460.2847,564,498.848,550,241.249,045,963.28
  开发支出10,058,684.649,361,527.768,271,120.566,358,092.61
  长期待摊费用26,363,243.0829,378,185.0831,370,779.3834,222,550.74
  递延所得税资产41,688,423.1939,599,537.1338,493,060.9835,982,138.97
  其他非流动资产146,147,981.6124,039,048.1349,033,762.2911,939,894.55
  非流动资产合计1,038,737,191.681,016,729,686.4931,542,907.09862,871,431.31
  资产总计2,830,055,938.712,798,490,402.032,650,964,333.252,572,645,275.65
流动负债:
  短期借款255,366,399.06240,589,606.23139,546,896.0988,040,399
  应付票据及应付账款67,683,970.3564,809,103.2965,647,143.0572,175,024.01
        应付账款67,683,970.3564,809,103.2965,647,143.0572,175,024.01
  合同负债147,802,147.91134,238,146.53133,829,803.42138,225,648.01
  应付职工薪酬39,783,564.933,279,578.3528,180,738.8950,060,232.24
  应交税费11,336,509.447,549,826.246,414,399.014,514,338.73
  其他应付款合计6,438,135.6551,385,161.639,955,786.089,360,340.96
        应付股利-44,988,970.18--
  一年内到期的非流动负债14,152,221.6911,906,543.2914,402,005.648,819,637.38
  流动负债平衡项目0.010-0.010
  流动负债合计542,562,949.01543,757,965.56397,976,772.17371,195,620.33
非流动负债:
  租赁负债57,879,715.857,317,990.9361,893,839.1635,621,508.96
  递延收益18,820,131.1920,493,001.1121,229,871.0222,902,740.95
  递延所得税负债9,746,814.179,009,276.047,942,517.268,199,085.8
  非流动负债合计86,446,661.1686,820,268.0891,066,227.4466,723,335.71
  负债合计629,009,610.17630,578,233.64489,042,999.61437,918,956.04
所有者权益(或股东权益):
  实收资本(或股本)410,000,000410,000,000410,000,000410,000,000
  资本公积1,253,258,796.391,251,028,660.711,261,606,295.21,261,144,258.89
  减:库存股22,903,999.3314,730,302.9435,819,316.3232,670,348.88
  其他综合收益8,167,178.38,084,054.898,540,845.598,639,160.83
  盈余公积52,305,892.2252,305,892.2252,305,892.2252,305,892.22
  未分配利润500,218,460.96461,223,863.51465,287,616.95435,307,356.55
  归属于母公司股东权益合计2,201,046,328.542,167,912,168.392,161,921,333.642,134,726,319.61
  股东权益合计2,201,046,328.542,167,912,168.392,161,921,333.642,134,726,319.61
  负债和股东权益合计2,830,055,938.712,798,490,402.032,650,964,333.252,572,645,275.65
公告日期2025-10-232025-08-232025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑